Department of Cardiovascular Diseases, Mayo Clinic, Rochester, Minnesota, USA.
Radiology, Mayo Clinic, Rochester, Minnesota, USA.
Stroke Vasc Neurol. 2022 Jun;7(3):251-257. doi: 10.1136/svn-2021-000939. Epub 2022 Mar 3.
We sought to determine the safety and efficacy in secondary stroke prevention of carotid endarterectomy (CEA) in patients with symptomatic non-stenotic carotid artery disease (SyNC).
This was a single-centre retrospective case series. All patients who underwent CEA for unilateral anterior circulation cerebrovascular events with ipsilateral <50% carotid stenosis from 2002 to 2020 were included. Imaging hallmarks including the degree of luminal stenosis and the presence of various vulnerable plaque characteristics (eg, intraplaque haemorrhage (IPH) on MR angiography, ulceration or low-density plaque on CT angiography) were assessed. The presence of vulnerable plaque characteristics was compared between arteries ipsilateral to the ischaemic event and contralateral arteries. The prevalence of perioperative/intraoperative complications, as well as recurrent ischaemic events at follow-up was determined.
Thirty-two patients were included in the analysis, of which 25.0% were female. Carotid arteries ipsilateral to an ischaemic event had a significantly higher prevalence of IPH when compared with contralateral arteries (80.0% vs 0.0%; p<0.001). There were no intraoperative complications. One patient (3.1%) developed symptoms of transient ipsilateral ischaemia 1 day following CEA which resolved without treatment. In a median follow-up of 18.0 months (IQR 5.0-36.0), only one patient (3.1%) experienced a transient neurologic deficit with complete resolution (annualised rate of recurrent stroke after CEA of 1.5% for a total follow-up of 788 patient-months following CEA). All other patients (31/32, 96.9%) were free of recurrent ischaemic events.
CEA appears to be safe and well-tolerated in patients with SyNC. Additional studies with larger cohorts and longer follow-up intervals are needed in order to determine the role of CEA in this patient population.
我们旨在确定症状性非狭窄性颈动脉疾病(SyNC)患者颈动脉内膜切除术(CEA)在二级卒中预防中的安全性和有效性。
这是一项单中心回顾性病例系列研究。纳入了 2002 年至 2020 年间因单侧前循环脑血管事件而行 CEA 的所有患者,这些患者的同侧颈动脉狭窄<50%。评估了影像学特征,包括管腔狭窄程度和各种易损斑块特征的存在(例如,磁共振血管造影上的斑块内出血(IPH)、CT 血管造影上的溃疡或低密度斑块)。比较了缺血事件同侧动脉和对侧动脉之间易损斑块特征的存在情况。确定了围手术期/术中并发症的发生率以及随访期间复发性缺血事件的发生率。
分析纳入了 32 例患者,其中 25.0%为女性。与对侧动脉相比,发生缺血事件同侧的颈动脉 IPH 的发生率明显更高(80.0% vs 0.0%;p<0.001)。无术中并发症。1 例患者(3.1%)在 CEA 后 1 天出现短暂同侧缺血症状,未经治疗缓解。在中位随访 18.0 个月(IQR 5.0-36.0)中,仅有 1 例患者(3.1%)经历短暂的神经功能缺损,完全缓解(CEA 后 788 个患者月的总随访中,CEA 后复发性卒中的年发生率为 1.5%)。所有其他患者(31/32,96.9%)均无复发性缺血事件。
CEA 似乎对 SyNC 患者安全且耐受良好。需要进一步开展队列更大、随访时间更长的研究,以确定 CEA 在该患者人群中的作用。